Sinovac and AstraZeneca vaccines producing high antibody levels - SICRES

13 Sept 11:00 Key points summarised by AI

Research by SICRES confirms both Sinovac and AstraZeneca vaccines generate high antibody levels, comparable to those in individuals recovered from COVID-19.
After one dose, AstraZeneca recipients universally develop high antibodies, while 75% of Sinovac recipients achieve similar levels; a second Sinovac dose elevates antibodies to match recovered patients.
Mild side effects, such as muscle pain and fatigue, were reported by 75% of vaccinated individuals, resolving without intervention.
Separate research indicates two doses of Sinovac reduce COVID-19 infection risk by 84%, significantly higher than the 37% reduction from a single dose.

Flooding persists in Bangkok and 22 provinces

Today 16:00 Key points summarised by AI

Persistent flooding continues across Bangkok and 22 Thai provinces, though water levels are gradually receding in many affected areas.
Over 604,000 families, impacting approximately 1.83 million people, are still grappling with the widespread flood conditions.
The national flood death toll has reached 80 since mid-September, with fatalities reported across various provinces.
Major regions like Pathum Thani, Ayutthaya, and Bangkok report significant numbers of affected households, with hundreds of thousands still in trouble.